Prospective, Non-interventional Study to Evaluate Immunogenicity of AryoSeven

NCT03372993 · clinicaltrials.gov ↗

COMPLETED

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia A With Inhibitor
Hemophilia B With Inhibitor
Factor VII Deficiency
Glanzmann's Thrombasthenia

Sponsor

AryoGen Pharmed Co.